Latest News about NVAX
Recent news which mentions NVAX
From Benzinga
FDA Approves Novavax's COVID-19 Vaccine For Use In Adolescents
August 22, 2022
Tickers
NVAX
From Benzinga
The Rise and Fall of Novavax
August 21, 2022
From Motley Fool
2 Overrated Growth Stocks I Wouldn't Buy With Free Money
August 19, 2022
From Motley Fool
Large-scale study finds COVID patients at higher risk of brain fog and psychosis after two years compared with other respiratory illnesses
August 18, 2022
From MarketWatch
How Investors Can Outperform Warren Buffett
August 18, 2022
From Motley Fool
From Benzinga
If You Invested $1,000 In Johnson & Johnson Stock At Its COVID-19 Pandemic Low, Here's How Much You'd Have Now
August 17, 2022
From Benzinga
Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary
August 17, 2022
From Benzinga
From Benzinga
From Benzinga
Why Blue Water Vaccines Is Trading Higher By Around 80%, Here Are 61 Stocks Moving In Wednesday's Mid-Day Session
August 17, 2022
From Benzinga
Recap Of Monday's Biotech Catalysts - End Of the Day Summary
August 15, 2022
From Benzinga
U.K. regulator is first to authorize Moderna’s bivalent COVID booster for adults aged 18 and older
August 15, 2022
From MarketWatch
From Motley Fool
Recap Of Friday's Biotech Catalysts - End Of the Day Summary
August 12, 2022
From Benzinga
1 Robinhood Stock to Avoid Right Now
August 12, 2022
From Motley Fool
Tickers
NVAX
From Motley Fool
From Motley Fool
1 Reason to Sell Novavax Stock, and 1 Reason to Buy
August 10, 2022
From Motley Fool
Peak Inflation: July CPI Report Was Much Better Than Expected
August 10, 2022
From Benzinga
From Benzinga
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.